Document_And_Entity_Informatio
| Document And Entity Information | 6 Months Ended | |
| Sep. 30, 2013 | Nov. 07, 2013 | |
| Document And Entity Information [Abstract] | ' | ' |
| Document Fiscal Year Focus | '2014 | ' |
| Document Fiscal Period Focus | 'Q2 | ' |
| Entity Registrant Name | 'Investors Capital Holdings LTD | ' |
| Entity Central Index Key | '0001001871 | ' |
| Current Fiscal Year End Date | '--03-31 | ' |
| Entity Filer Category | 'Smaller Reporting Company | ' |
| Entity Common Stock, Shares Outstanding | ' | 7,096,723 |
| Amendment Flag | 'false | ' |
| Document Period End Date | 30-Sep-13 | ' |
| Document Type | '10-Q | ' |
Condensed_Consolidated_Balance
| Condensed Consolidated Balance Sheets (USD $) | Sep. 30, 2013 | Mar. 31, 2013 |
| Current Assets | ' | ' |
| Cash and cash equivalents | $6,233,331 | $6,589,698 |
| Deposit with clearing organization, restricted | 175,000 | 175,000 |
| Accounts receivable and Other receivables | 5,875,628 | 7,160,553 |
| Loans receivable from registered representatives (current), net of allowance | 710,949 | 593,730 |
| Prepaid income taxes | 186,050 | 136,972 |
| Securities owned at fair value | 277,031 | 258,903 |
| Prepaid expenses | 422,721 | 722,427 |
| Total current assets | 13,880,710 | 15,637,283 |
| Property and equipment, net | 108,330 | 194,446 |
| Long Term Assets | ' | ' |
| Loans receivable from registered representatives | 1,039,744 | 893,703 |
| Non-qualified deferred compensation investment | 2,148,276 | 1,771,044 |
| Cash surrender value life insurance policies | 204,731 | 176,402 |
| Total long term investments | 3,392,751 | 2,841,149 |
| Other Assets | ' | ' |
| Deferred tax asset, net | 1,507,116 | 1,059,480 |
| Capitalized software, net | 81,931 | 107,590 |
| Other assets | 56,704 | 56,704 |
| Total other assets | 1,645,751 | 1,223,774 |
| TOTAL ASSETS | 19,027,542 | 19,896,652 |
| Current Liabilities | ' | ' |
| Accounts payable | 748,983 | 1,327,691 |
| Accrued expenses | 2,643,550 | 1,818,379 |
| Commissions payable | 3,359,332 | 3,279,921 |
| Notes payable | 431,690 | 1,488,876 |
| Unearned revenue | 522,608 | 188,651 |
| Securities sold, not yet purchased, at fair value | 44,698 | 28,946 |
| Total current liabilities | 7,750,861 | 8,132,464 |
| Long-Term Liabilities | ' | ' |
| Non-qualified deferred compensation plan | 2,383,870 | 1,968,691 |
| Subordinated borrowings | 2,000,000 | 2,000,000 |
| Total Long-Term Liabilities | 4,383,870 | 3,968,691 |
| Total liabilities | 12,134,731 | 12,101,155 |
| Stockholders' Equity: | ' | ' |
| Common stock, $.01 par value, 10,000,000 shares authorized; 7,100,608 issued and 7,096,723 outstanding at September 30, 2013; 7,101,427 issued and 7,097,542 outstanding at March 31, 2013 | 70,957 | 71,013 |
| Additional paid-in capital | 12,832,838 | 12,594,370 |
| Accumulated deficit | -5,980,849 | -4,839,751 |
| Less: Treasury stock, 3,885 shares at cost | -30,135 | -30,135 |
| Total stockholders' equity | 6,892,811 | 7,795,497 |
| TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY | $19,027,542 | $19,896,652 |
Condensed_Consolidated_Balance1
| Condensed Consolidated Balance Sheets (Parenthetical) (USD $) | Sep. 30, 2013 | Mar. 31, 2013 |
| Condensed Consolidated Balance Sheets [Abstract] | ' | ' |
| Common stock, par value | $0.01 | $0.01 |
| Common stock, shares authorized | 10,000,000 | 10,000,000 |
| Common stock, shares issued | 7,100,608 | 7,101,427 |
| Common stock, shares outstanding | 7,096,723 | 7,097,542 |
| Treasury stock, shares | 3,885 | 3,885 |
Condensed_Consolidated_Stateme
| Condensed Consolidated Statements Of Operations (USD $) | 3 Months Ended | 6 Months Ended | ||
| Sep. 30, 2013 | Sep. 30, 2012 | Sep. 30, 2013 | Sep. 30, 2012 | |
| Revenue: | ' | ' | ' | ' |
| Commissions | $17,016,527 | $15,779,387 | $35,157,412 | $31,867,893 |
| Advisory fees | 4,535,767 | 3,979,313 | 8,978,549 | 8,089,985 |
| Other fee income | 313,906 | 337,226 | 533,127 | 676,330 |
| Other revenue | 411,604 | 226,839 | 691,709 | 491,082 |
| Total revenue | 22,277,804 | 20,322,765 | 45,360,797 | 41,125,290 |
| Expenses: | ' | ' | ' | ' |
| Commissions and advisory fees | 17,871,474 | 16,126,655 | 36,611,321 | 32,736,807 |
| Compensation and benefits | 1,613,175 | 1,460,708 | 3,351,472 | 3,039,968 |
| Regulatory, legal and professional services | 2,066,087 | 977,627 | 3,869,290 | 1,853,258 |
| Brokerage, clearing and exchange fees | 355,223 | 364,697 | 748,966 | 702,798 |
| Technology and communications | 373,909 | 327,240 | 716,773 | 624,218 |
| Advertising, marketing and promotion | 427,118 | 231,424 | 787,906 | 472,698 |
| Occupancy and equipment | 136,240 | 178,191 | 221,528 | 364,299 |
| Other administrative | 261,462 | 221,748 | 495,510 | 438,778 |
| Interest | 87,459 | 4,835 | 142,482 | 13,803 |
| Total operating expenses | 23,192,147 | 19,893,125 | 46,945,248 | 40,246,627 |
| Operating (loss) income | -914,343 | 429,640 | -1,584,451 | 878,663 |
| (Benefit) provision for income taxes | -132,825 | 149,420 | -443,352 | 336,760 |
| Net (loss) income | ($781,518) | $280,220 | ($1,141,099) | $541,903 |
| Basic net (loss) income per share | ($0.12) | $0.04 | ($0.17) | $0.08 |
| Diluted net (loss) income per share | ($0.12) | $0.04 | ($0.17) | $0.08 |
| Weighted average shares used in basic per share calculations | 6,707,905 | 6,529,786 | 6,701,299 | 6,625,771 |
| Weighted average shares used in diluted per share calculations | 6,707,905 | 6,656,165 | 6,701,299 | 6,746,905 |
Condensed_Consolidated_Stateme1
| Condensed Consolidated Statements Of Cash Flows (USD $) | 6 Months Ended | |
| Sep. 30, 2013 | Sep. 30, 2012 | |
| Cash flows from operating activities: | ' | ' |
| Net (loss) income | ($1,141,099) | $541,903 |
| Adjustments to reconcile net (loss) income to net cash provided by operating activities: | ' | ' |
| Depreciation and amortization | 120,829 | 164,017 |
| Deferred taxes, net | -447,636 | 445,240 |
| Stock-based compensation | 197,884 | 90,903 |
| Unrealized gain (loss) in marketable securities | 14,618 | -19,974 |
| Non-qualified deferred compensation investment | 32,934 | 30,394 |
| Market adjustment cash surrender value life insurance policy | -10,329 | -1,519 |
| Charge to commission expense (forgivable loans) | 218,211 | 174,359 |
| Allowance for bad debt expense | 5,000 | 2,708 |
| Change in operating assets and liabilities: | ' | ' |
| Accounts receivable and Other receivables | 1,284,925 | -403,682 |
| Prepaid expenses and other | 304,719 | -142,391 |
| Loans receivable from registered representatives | -486,471 | -102,984 |
| Income taxes | -49,078 | -33,480 |
| Accounts payable | -578,708 | 185,720 |
| Securities, net | ' | 7,863 |
| Accrued expenses | 825,171 | -41,076 |
| Commissions payable | 79,411 | 43,283 |
| Unearned revenue | 333,957 | 306,363 |
| Net cash provided by operating activities | 704,338 | 1,247,647 |
| Cash flows from investing activities: | ' | ' |
| Acquisition of property and equipment | -9,054 | -4,684 |
| Cash surrender value life insurance policies | -18,000 | ' |
| Proceeds from investments | -16,994 | ' |
| Net cash used in investing activities | -44,048 | -4,684 |
| Cash flows from financing activities: | ' | ' |
| Excess tax benefit related to stock awards | 40,529 | ' |
| Payments on note payable | -1,057,186 | -1,298,392 |
| Net cash used in financing activities | -1,016,657 | -1,298,392 |
| Net decrease in cash and cash equivalents | -356,367 | -55,429 |
| Cash and cash equivalents, beginning of period | 6,589,698 | 4,537,713 |
| Cash and cash equivalents, end of period | 6,233,331 | 4,482,284 |
| Supplemental disclosures of cash flow information: | ' | ' |
| Interest paid | 13,774 | 13,803 |
| Income taxes paid | $11,000 | ' |
Organization_And_Basis_Of_Pres
| Organization And Basis Of Presentation | 6 Months Ended | |
| Sep. 30, 2013 | ||
| Organization And Basis Of Presentation [Abstract] | ' | |
| Organization And Basis Of Presentation | ' | |
| Note 1 – Organization AND Basis of Presentation | ||
| Incorporated in 1995 under Massachusetts law and redomesticated under Delaware law in 2007, Investors Capital Holdings, Ltd. ("ICH") is a holding company whose wholly-owned subsidiaries assist a nationwide network of independent registered representatives ("representatives") in providing a diversified line of financial services to the public including securities brokerage, investment advice, asset management, financial planning and insurance. Our subsidiaries include the following: | ||
| · | Investors Capital Corporation ("ICC") is duly registered under the Securities Exchange Act of 1934, the Investment Advisers Act of 1940 and applicable state law to provide broker-dealer and investment advisory services nationwide. ICC’s national network of independent financial representatives is licensed to provide these services through ICC under the regulatory purview of the Securities and Exchange Commission (the “SEC”), the Financial Industry Regulatory Authority (“FINRA”) and state securities regulators. ICC executes and clears its public customer accounts on a fully disclosed basis through Pershing, LLC (“Pershing”). ICC, doing business as Investors Capital Advisors (“ICA”), also provides investment advisory services. | |
| · | ICC Insurance Agency, Inc. (“ICCIA”) facilitates the sale of insurance and annuities by our representatives. | |
| · | Investors Capital Holdings Securities Corporation ("ICH Securities") holds cash, cash equivalents, interest income and dividend income for ICH. | |
| · | Advisor Direct, Incorporated (“AD”) is a wholly-owned subsidiary. On January 24, 2013, Investors Capital Holdings, Ltd. acquired all the assets of a shell broker-dealer for the cash purchase price of $32,500. AD is a Broker-Dealer registered with the SEC and is a member of FINRA. AD is registered to operate as a (k)(1) Broker-Dealer where principal transactions are limited to mutual funds and/or variable annuities only. | |
| BASIS OF PRESENTATION: | ||
| The condensed consolidated financial statements are unaudited and have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. In the opinion of management, the interim data includes all adjustments, consisting of normal recurring adjustments, necessary for a fair statement of the results for the periods presented. Because of the nature of the Company’s business, interim period results may not be indicative of full year or future results. | ||
| The accompanying interim unaudited condensed consolidated financial statements of Investors Capital Holdings, Ltd. and its subsidiaries (the “Company”) have been prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”) for interim financial information and with the instructions to Quarterly Report on Form 10-Q. Accordingly, they do not include all of the information and footnotes required by US GAAP for complete financial statements. In the opinion of management, these financial statements contain all of the adjustments necessary for a fair presentation of the results of the interim periods presented. Operating results for the three months and six months period ended September 30, 2013 are not necessarily indicative of the results that may be expected for the year ending March 31, 2014. The balance sheet at March 31, 2013 has been derived from the audited financial statements at that date, but does not include all of the information and footnotes required by US GAAP for complete financial statement presentation. For further information, refer to the audited consolidated financial statements and footnotes thereto included in the Company’s Annual Report on Form 10-K (the “Form 10-K”) for the fiscal year ended March 31, 2013 filed with the SEC, for additional disclosures and a description of accounting policies. | ||
| There have been no material changes from the critical accounting policies set forth in Item 7, “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” of our annual report on Form 10-K for the year ended March 31, 2013. Please refer to those sections for disclosures regarding the critical accounting policies related to our business | ||
| Certain prior year items have been reclassified to conform to the current period’s presentation. These reclassifications had no effect on previously reported results of operations. All significant intercompany balances and transactions have been eliminated. The Company has evaluated subsequent events through the date of this filing. | ||
Loans_To_Registered_Representa
| Loans To Registered Representatives | 6 Months Ended | |||||
| Sep. 30, 2013 | ||||||
| Loans To Registered Representatives [Abstract] | ' | |||||
| Loans To Registered Representatives | ' | |||||
| Note 2 - Loans to Registered Representatives | ||||||
| ICC has granted loans to certain registered representatives with the stipulation that the loans will be forgiven if the representatives remain licensed with the Company for an agreed upon period of time, generally one to five years, and/or meet specified performance and/or revenue targets. Upon forgiveness, the loans are charged to commission expense for financial reporting purposes. Loans charged to commission expense totaled $82,950 and $86,379, for the three months period ended September 30, 2013 and 2012, respectively and $218,211 and $174,359 for the six months period ended September 30, 2013 and 2012, respectively. | ||||||
| Some loans to registered representatives are not subject to a forgiveness contingency. These loans, as well as loans that have failed the forgiveness contingency, are repaid to the Company by deducting a portion of the representatives’ commission payouts throughout the commission cycle until the loans are repaid. | ||||||
| Interest charged on these loans to representatives range from 4.25% to 8.25% annually. Loans to registered representatives are as follows: | ||||||
| 30-Sep-13 | 31-Mar-13 | |||||
| Forgivable loans | $ | 1,353,806 | $ | 1,115,765 | ||
| Other loans | 619,483 | 604,264 | ||||
| Less: allowance | -222,596 | -232,596 | ||||
| Total loans | $ | 1,750,693 | $ | 1,487,433 | ||
| Included in other loans is a loan receivable from a registered representative in connection with a regulatory matter settled with the Massachusetts Securities Division on October 27, 2010. This representative has agreed to reimburse the Company for certain amounts paid by the Company with respect to this regulatory matter. The amount due on this receivable at September 30, 2013 and March 31, 2013 was $304,758 and $330,587, respectively. | ||||||
Income_Taxes
| Income Taxes | 6 Months Ended |
| Sep. 30, 2013 | |
| Income Taxes [Abstract] | ' |
| Income Taxes | ' |
| NOTE 3 - INCOME TAXES | |
| The Company uses the asset and liability method to account for income taxes, which requires recognition of deferred tax assets, subject to valuation allowances, and liabilities for the expected future tax consequences of events that have been included in the financial statements or tax returns. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income or loss in the period that includes the enactment date. | |
| The Company, in preparing its income tax provision, bases the calculation on its annual projection of income or loss from operations. The annual projection is reconciled on a quarterly basis to changes in estimates, and at year end the calculation is based on the reported results of operations. Certain expenses are not deductible for tax purposes, creating permanent differences that increase or decrease the income tax provision and effective income tax rate. | |
| Deferred income taxes are the result of timing differences between book and taxable income and consist primarily of representative deferred compensation, legal settlement accruals, differences between depreciation expenses, and a state net operating loss for financial statement purposes versus tax return purposes. | |
| The Company assesses the realizability of its deferred tax assets to determine whether or not a valuation allowance was required for some or all of its deferred tax assets. The Company considered negative evidence, including its current cumulative loss position for financial reporting purposes over the past three fiscal years, and positive evidence, including its recent earnings and history of taxable income in three of the past five years and its projections of taxable income in the future. The Company also considered that its GAAP losses generated in prior fiscal years included certain significant non-deductible and other non-recurring expenses. | |
| Management concluded that due to the lack of predictability of financial markets, recent instability along with the ongoing regulatory and legal risks and their related defense costs inherent in our industry necessitate we maintain a valuation allowance of approximately $0.5 million. If future operations exceed current projections, management may conclude such valuation allowance is no longer needed. Conversely, if future operating results do not meet current projections, it is possible that an additional valuation allowance may be needed in future periods. | |
| The Company recognizes and measures its unrecognized tax benefit or expense. The Company assesses the likelihood, based on their technical merit, that tax positions will be sustained upon examination based on the facts, circumstances and information available at the end of each period. The measurement of unrecognized tax expense or benefit is adjusted when new information is available or when an event occurs that requires a change. The Company recognizes the accrual of any interest and penalties related to unrecognized tax expense in income tax expense. No interest or penalties were recognized for the three months and six months period ended September 30, 2013 and 2012. The Company does not have any tax positions as of September 30, 2013 for which it is reasonably possible that the total amounts of unrecognized tax benefit or expense will significantly increase or decrease within twelve months of the reporting date. | |
Fair_Value_Measurements
| Fair Value Measurements | 6 Months Ended | ||||||||||||
| Sep. 30, 2013 | |||||||||||||
| Fair Value Measurements [Abstract] | ' | ||||||||||||
| Fair Value Measurements | ' | ||||||||||||
| NOTE 4 – FAIR VALUE MEASUREMENTS | |||||||||||||
| The Company’s assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to the asset or liability. Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. A fair value measurement assumes that the transaction to sell the asset or transfer the liability occurs in the principal market for the asset or liability or, in the absence of a principal market, the most advantageous market. Valuation techniques that are consistent with the market, income or cost approach are used to measure fair value. | |||||||||||||
| The fair value hierarchy prioritizes the inputs to valuation techniques used to measure fair value into three broad levels: | |||||||||||||
| · | Level 1 - Inputs are unadjusted quoted prices in active markets for identical assets or liabilities the Company have the ability to access. | ||||||||||||
| · | Level 2 - Inputs are inputs (other than quoted prices included within Level 1) that are observable for the asset or liability, either directly or indirectly. | ||||||||||||
| · | Level 3 - Inputs include unobservable inputs for the asset or liability and rely on management's own assumptions about the assumptions that market participants would use in pricing the asset or liability. (The unobservable inputs should be developed based on the best information available in the circumstances and may include the Company’s own data.) | ||||||||||||
| The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities. The following table presents the Company's fair value hierarchy for those financial assets and liabilities measured at fair value as of September 30, 2013: | |||||||||||||
| Fair Value Measurements on Recurring Basis | |||||||||||||
| Assets: | Total | Level 1 | Level 2 | Level 3 | |||||||||
| Securities owned at fair value | |||||||||||||
| Mutual funds | $ | 273,919 | $ | 273,919 | $ | - | $ | - | |||||
| Equities | 1,306 | 1,306 | - | - | |||||||||
| Asset backed securities | 1,806 | - | 1,806 | - | |||||||||
| Total Assets | $ | 277,031 | $ | 275,225 | $ | 1,806 | $ | - | |||||
| Liabilities: | |||||||||||||
| Securities sold, not yet purchased at fair value | |||||||||||||
| Exchange traded funds | $ | 17,818 | $ | 17,818 | $ | - | $ | - | |||||
| Equities | 26,880 | 26,880 | - | - | |||||||||
| Total Liabilities | $ | 44,698 | $ | 44,698 | $ | - | $ | - | |||||
| The following table presents the Company's fair value hierarchy for those financial assets and liabilities measured at fair value as of March 31, 2013: | |||||||||||||
| Fair Value Measurements on Recurring Basis | |||||||||||||
| Total | Level 1 | Level 2 | Level 3 | ||||||||||
| Assets: | |||||||||||||
| Securities owned at fair value | |||||||||||||
| Mutual funds | $ | 256,509 | $ | 256,509 | $ | - | $ | - | |||||
| Equities | 354 | 354 | - | - | |||||||||
| Asset backed securities | 2,040 | - | 2,040 | - | |||||||||
| Total assets | $ | 258,903 | $ | 256,863 | $ | 2,040 | $ | - | |||||
| Liabilities: | |||||||||||||
| Securities sold, not yet purchased at fair value | |||||||||||||
| Equities | 28,946 | 28,946 | - | - | |||||||||
| Total Liabilities | $ | 28,946 | $ | 28,946 | $ | - | $ | - | |||||
NonQualified_Deferred_Compensa
| Non-Qualified Deferred Compensation Plan | 6 Months Ended |
| Sep. 30, 2013 | |
| Non-Qualified Deferred Compensation Plan [Abstract] | ' |
| Non-Qualified Deferred Compensation Plan | ' |
| NOTE 5 – Non-Qualified Deferred Compensation Plan | |
| Effective December 2007, the Company established the Investors Capital Holdings, Ltd. Deferred Compensation Plan (the “NQ Plan”) as well as a Rabbi Trust Agreement for this Plan, for which ICC is the NQ Plan’s sponsor. The unfunded NQ Plan enables eligible ICC’s Representatives to elect to defer a portion of earned commissions, as defined by the NQ Plan. The asset represents the representatives’ invested contributions of deferred commissions, investment gains and losses as well as insurance charges while the liability is comprised of the participant deferrals, unrealized gains and losses and any distributions. The total amount of deferred compensation was $149,225 and $108,710 for the three months period ended September 30, 2013 and 2012, respectively and $302,337 and $214,432 for the six months period ended September 30, 2013 and 2012, respectively. | |
Litigation_And_Regulatory_Matt
| Litigation And Regulatory Matters | 6 Months Ended |
| Sep. 30, 2013 | |
| Litigation And Regulatory Matters [Abstract] | ' |
| Litigation And Regulatory Matters | ' |
| NOTE 6 - LITIGATION AND REGULATORY MATTERS | |
| In the ordinary course of business, the Company and its subsidiaries are routinely defendants in or parties to arbitrations and other legal actions and proceedings brought on behalf of various claimants, some of which seek material and/or indeterminable amounts. Certain of these actions and proceedings are based on alleged violations of securities, consumer protection, labor and other laws and may involve claims for substantial monetary damages asserted against the Company and its subsidiaries. Also, the Company and its subsidiaries are subject to regulatory examinations, information gathering requests, inquiries, investigations and formal administrative proceedings that may result in fines or other negative impact on the Company. ICC, as a duly registered broker/dealer and investment advisor, is subject to regulation by the SEC, FINRA, NYSE-Amex, and state securities regulators. | |
| The Company maintains Errors and Omissions (“E&O”) insurance to protect itself from potential damages and/or legal costs associated with certain litigation and arbitration proceedings and, as a result, in the majority of cases, the Company’s exposure is limited to $100,000, or $1,000,000 aggregate (effective January 2013 for only certain alternative investment products related to defense costs and indemnities) in any one case, subject to policy limitations and exclusions. Thereafter the $1,000,000 aggregate threshold, the Company’s exposure on these same investments is limited to $150,000 and a ten (10) percent coinsurance. For all other investment products, the Company’s exposure is $100,000 per claim. | |
| The Company also maintains a fidelity bond to protect itself from potential damages and/or legal costs related to fraudulent activities pursuant to which the Company’s exposure is usually limited to a $350,000 deductible per case, subject to policy limitations and exclusions. | |
| The Company recognizes a legal liability when management believes it is probable that a liability has been incurred and the amount can be reasonably estimated. Conclusions on the likelihood that a liability has been incurred and estimates as to the amount of the liability are based on consultations with the Company’s General Counsel who, when situations warrant, may engage and consult external counsel to assist with the evaluation and handle certain matters. Legal fees for defense costs are expensed as incurred and classified as professional services within the consolidated statements of income. | |
| As of September 30, 2013 and March 31, 2013, the Company had accrued professional fees relating to the Company’s defense in various legal matters and estimated probable settlement costs of approximately $2,671,834 and $1,534,660, respectively, included in accrued expenses and accounts payable. On October 28, 2013 litigation for a single class action trustee was settled for $2,005,000 which is adjusted and accrued as of September 30, 2013. Additionally, amounts due from the Company’s insurance carrier, totaling $1,000,000, are included in accounts receivable and other receivables on the consolidated balance sheet and included as a reduction of regulatory, legal and professional services in the condensed consolidated statement of operations. | |
| It is possible that some of the matters could require the Company to pay damages or make other payments or establish accruals in amounts that could not be estimated and/or could exceed those accrued as of September 30, 2013. Key components of the accrual include claims arising from alleged poor performance of certain alternative investments in real estate investments trusts that have experienced bankruptcy or other financial difficulties during or in connection with the recent recession and credit crisis. | |
Stock_Based_Compensation
| Stock Based Compensation | 6 Months Ended | ||||||||||
| Sep. 30, 2013 | |||||||||||
| Stock Based Compensation [Abstract] | ' | ||||||||||
| Stock Based Compensation | ' | ||||||||||
| Note 7 - Stock Based Compensation | |||||||||||
| The Company periodically issues common stock to employees, directors, officers, representatives and other key individuals in accordance with the provisions of the shareholder approved equity compensation plans. The Company measures and recognizes compensation expense for all share-based awards made to representatives, officers, employees and directors based on estimated fair values. | |||||||||||
| Stock Awards | |||||||||||
| Shares of stock granted under the Company’s equity incentive plans (the “Equity Plans”) as of September 30, 2013 have been either fully vested at the date of grant or subject to vesting over time periods varying from one to seven years after the date of grant, unvested shares being subject to forfeiture in the event of termination of the grantee’s relationship with the Company, other than for death or disability. The compensation cost associated with these stock grants is recognized over the vesting period of the shares and is calculated as the market value of the shares on the date of grant. Stock grants have been recorded as deferred compensation, which is a component of paid-in capital within stockholders’ equity on the Company’s Condensed Consolidated Balance Sheets. | |||||||||||
| The following activity occurred during the three months ended September 30, 2013 and 2012: | |||||||||||
| Weighted Ave | Weighted Average | ||||||||||
| Shares | Stock Price | Vested Life | Fair Value | ||||||||
| Non-vested at July 1, 2013 | 413,634 | $ | 3.84 | 2.53 years | $ | 1,588,355 | |||||
| Granted | - | - | |||||||||
| Less: vested | -24,816 | 3.93 | -97,527 | ||||||||
| Less: canceled | - | - | - | ||||||||
| Non-vested at September 30, 2013 | 388,818 | $ | 3.83 | 2.30 years | $ | 1,489,173 | |||||
| Weighted Ave | Weighted Average | ||||||||||
| Shares | Stock Price | Vested Life | Fair Value | ||||||||
| Non-vested at July 1, 2012 | 63,976 | $ | 4.41 | 2.05 years | $ | 282,134 | |||||
| Granted | - | - | - | ||||||||
| Less: vested | -15,885 | 4.58 | -72,753 | ||||||||
| Less: canceled | -589 | 5.68 | -3,346 | ||||||||
| Non-vested at September 30, 2012 | 47,502 | $ | 4.33 | 1.95 years | $ | 205,684 | |||||
| The Company’s net loss for the three months ended September 30, 2013 includes $0.05 million of compensation costs related to the Company’s grants of restricted stock to employees, $0.01 for grants to directors and $0.04 million for grants to independent representatives under the Plans. In the prior period, the Company’s net income included $0.02 million in stock compensation to directors, and $0.03 million in stock compensation to independent representatives under the Equity Plans. | |||||||||||
| The following activity occurred during the six months ended September 30, 2013 and 2012: | |||||||||||
| Weighted Ave | Weighted Average | ||||||||||
| Shares | Stock Price | Vested Life | Fair Value $ | ||||||||
| Non-vested at 4/1/2013 | 440,437 | $ | 3.85 | 2.74 years | $ | 1,695,682 | |||||
| Granted | - | - | - | ||||||||
| Less: vested | -50,800 | $ | 3.94 | -200,152 | |||||||
| Less: canceled | -819 | 4.46 | -3,653 | ||||||||
| Non-vested at 9/30/2013 | 388,818 | $ | 3.83 | 2.30 years | $ | 1,489,173 | |||||
| Weighted Ave | Weighted Average | ||||||||||
| Shares | Stock Price | Vested Life | Fair Value $ | ||||||||
| Non-vested at 4/1/2012 | 77,402 | $ | 4.41 | 2.54 years | $ | 341,343 | |||||
| Granted | - | - | - | ||||||||
| Less: vested | -25,125 | 4.48 | -112,560 | ||||||||
| Less: canceled | -4,775 | 4.88 | -23,302 | ||||||||
| Non-vested at 9/30/2012 | 47,502 | $ | 4.33 | 1.95 years | $ | 205,684 | |||||
| The Company’s net loss for the six months ended September 30, 2013 includes $0.10 million of compensation costs related to the Company’s grants of restricted stock to employees, $0.02 for grants to directors and $0.08 million for grants to independent representatives under the Plans. In the prior period, the Company’s net income included $0.02 million in stock compensation to directors, and $0.06 million in stock compensation to independent representatives under the Equity Plans. | |||||||||||
| Stock Option Grants | |||||||||||
| The following table summarizes information regarding the Company's employee and director fixed stock options as of September 30, 2013 and, 2012: | |||||||||||
| Employee | |||||||||||
| 2013 | 2012 | ||||||||||
| Fixed Options | Weighted-Average | Weighted-Average | |||||||||
| Shares | Exercise Price | Shares | Exercise Price | ||||||||
| Outstanding at beginning of period | 150,000 | $1.00 | 150,000 | $1.00 | |||||||
| Granted | - | - | |||||||||
| Canceled | - | - | |||||||||
| Exercised | - | - | |||||||||
| Outstanding at end of period | 150,000 | $1.00 | 150,000 | $1.00 | |||||||
| Options exercisable at period end | 150,000 | 150,000 | |||||||||
| Weighted-average fair value of | |||||||||||
| options granted during the period | - | - | |||||||||
| The intrinsic value of the stock options was $654,000 at September 30, 2013 and $450,000 at September 30, 2012. | |||||||||||
| The following table summarizes further information about employee and Directors' fixed stock options outstanding as of September 30, 2013: | |||||||||||
| Options Outstanding | Options Exercisable | ||||||||||
| Range of Exercise Prices | Number Outstanding | Weighted-Average RemainingContractual Life | Exercise Price | Number Exercisable | Weighted-Average Exercise Price | ||||||
| $ | 1.00 | 150,000 | $ | 1.00 | 150,000 | $ | 1.00 | ||||
Segment_Information
| Segment Information | 6 Months Ended | |||||||||||
| Sep. 30, 2013 | ||||||||||||
| Segment Information [Abstract] | ' | |||||||||||
| Segment Information | ' | |||||||||||
| Note 8 - Segment Information | ||||||||||||
| Operating segments are defined as components of a business about which separate financial information is available that is regularly evaluated by management in deciding how to allocate resources and in assessing performance. The Company evaluates performance based on profit and loss from operations before income taxes not including nonrecurring gains and losses. | ||||||||||||
| The Company's has two operating segments, the independent broker-dealer provided by ICC and AD, and asset management and investment advisory services provided by ICA. ICCIA conducts the sale of insurance products and reports that activity at ICC. | ||||||||||||
| The segments are strategic business units that are managed separately. They operate under different regulatory systems, provide different services and require distinct marketing strategies and varied technological and operational support. They also have differing revenue models; ICC earns transactional commissions and various fees in connection with the brokerage of securities for its customers. ICCIA generates commissions from insurance products. ICA generates recurring revenue from fees earned on the value of assets under management. Lastly, AD is eligible to receive commissions on principal transactions of mutual funds and/or variable annuities only. AD, acquired on January 24, 2013, is operational but had no principal transactions during the current period. | ||||||||||||
| The Company accounts for inter-segment services and transfers as if the services or transfers were to third parties, that is, at current market prices. In presenting segment data, all corporate overhead items are allocated to the segments, and inter-segment revenue, expense, receivables and payables are eliminated. Currently it is impractical to report segment information using geographical concentration. | ||||||||||||
| Management allocates all expenses separately to the parent and ICC, including allocation of costs associated with shared personnel, based upon time studies and a determination of which entities are the beneficiaries of the services rendered by the personnel. Within ICC, expenses are further allocated between the two segments, ICC and ICA, as follows: overhead expenses pro rata to revenue, direct full-time and time-shared employee costs based on the segments being served, and other personnel-related expenses pro rata to head count. There is no allocation of expenses for AD there are only direct costs for regulatory and professional services in maintaining its shell broker-dealer status. | ||||||||||||
| In addition, ICC reimburses ICH in the form of a management fee for ICH-incurred overhead expenses that are necessary for ICC to effectively conduct its operations. This overhead primarily is in the nature of salaries and professional and legal fees incurred to obtain such services as audit engagements, legal advice, and industry expertise. The Company periodically reviews the effect that these agreements described above may have on the firm’s net capital. | ||||||||||||
| Segment reporting primarily based on revenue components is as follows for the three months ended: | ||||||||||||
| 30-Sep-13 | ||||||||||||
| Commissions | Advisory | ICH | ICH Securities | Totals | ||||||||
| Non-interest revenue | $ | 17,611,190 | 4,607,317 | -16,729 | - | $ | 22,201,778 | |||||
| Revenue from transaction with | ||||||||||||
| other operating segments: | $ | 297,889 | - | - | $ | 297,889 | ||||||
| Interest and dividend income, net | $ | 76,019 | - | 2 | 5 | $ | 76,026 | |||||
| Depreciation and amortization | $ | 59,430 | 917 | - | - | $ | 60,347 | |||||
| Income (loss) from operations | $ | -1,509,307 | 660,423 | -65,464 | 5 | $ | -914,343 | |||||
| Period end total assets | $ | 17,071,481 | 708,145 | 2,714,727 | 10,364 | $ | 20,504,717 | |||||
| Corporate items and eliminations | $ | - | - | -1,477,175 | - | $ | -1,477,175 | |||||
| 30-Sep-12 | ||||||||||||
| Commissions | Advisory | ICH | ICH Securities | Totals | ||||||||
| Non-interest revenue | $ | 16,237,978 | $ | 4,033,714 | $ | -17,445 | $ | - | $ | 20,254,247 | ||
| Revenue from transaction with | ||||||||||||
| other operating segments: | $ | 266,558 | - | - | $ | 266,558 | ||||||
| Interest and dividend income, net | $ | 68,513 | - | 7 | - | $ | 68,520 | |||||
| Depreciation and amortization | $ | 79,829 | 1,167 | - | - | $ | 80,996 | |||||
| Income (loss) from operations | $ | 10,888 | 532,696 | -113,951 | 7 | $ | 429,640 | |||||
| Period end total assets | $ | 13,933,230 | 456,591 | 2,912,360 | 10,343 | $ | 17,312,524 | |||||
| Corporate items and eliminations | $ | - | - | -1,728,824 | - | $ | -1,728,824 | |||||
| + | ||||||||||||
| Segment reporting primarily based on revenue components is as follows for the six months ended: | ||||||||||||
| 30-Sep-13 | ||||||||||||
| Commissions | Advisory | ICH | ICH Securities | Totals | ||||||||
| Non-interest revenue | $ | 36,168,380 | 9,084,641 | -32,873 | - | $ | 45,220,148 | |||||
| Revenue from transaction with | ||||||||||||
| other operating segments: | $ | 632,264 | - | - | - | $ | 632,264 | |||||
| Interest and dividend income, net | $ | 140,638 | 2 | 10 | $ | 140,650 | ||||||
| Depreciation and amortization | $ | 119,912 | 917 | - | - | $ | 120,829 | |||||
| Income (loss) from operations | $ | -2,607,945 | 1,145,571 | -122,087 | 10 | $ | -1,584,451 | |||||
| Period end total assets | $ | 17,071,481 | 708,145 | 2,714,727 | 10,364 | $ | 20,504,717 | |||||
| Corporate items and eliminations | $ | - | - | -1,477,175 | - | $ | -1,477,175 | |||||
| 30-Sep-12 | ||||||||||||
| Commissions | Advisory | ICH | ICH Securities | Totals | ||||||||
| Non-interest revenue | $ | 32,799,117 | $ | 8,209,373 | $ | -30,373 | $ | - | $ | 40,978,117 | ||
| Revenue from transaction with | ||||||||||||
| other operating segments: | $ | 496,474 | - | - | - | $ | 496,474 | |||||
| Interest and dividend income, net | $ | 147,160 | - | 13 | - | $ | 147,173 | |||||
| Depreciation and amortization | $ | 162,850 | 1,167 | - | - | $ | 164,017 | |||||
| Income (loss) from operations | $ | 29,554 | 1,140,811 | -291,715 | 13 | $ | 878,663 | |||||
| Period end total assets | $ | 13,933,230 | 456,591 | 2,912,360 | 10,343 | $ | 17,312,524 | |||||
| Corporate items and eliminations | $ | - | - | -1,728,824 | - | $ | -1,728,824 | |||||
Subsequent_Events
| Subsequent Events | 6 Months Ended |
| Sep. 30, 2013 | |
| Subsequent Events [Abstract] | ' |
| Subsequent Events | ' |
| NOTE 9- SUBSEQUENT EVENTS | |
| The Company has evaluated subsequent events through the date the financial statements were available to be filed. On October 2, 2013, RCS Capital Corporation (NYSE: RCAP) (“RCAP”) and Investors Capital Holdings, LTD. (“ICH”) announced its entry on October 1, 2013 into a letter of intent (the “Letter of Intent”) under which RCAP expects to acquire ICH for aggregate consideration of approximately $52.2 million or for a share purchase price of $7.35 for each share of ICH common stock outstanding, on a fully diluted basis. Final terms are expected in a Definitive Merger Agreement. Pursuant to the terms of the letter of intent, the definitive merger agreement between the RCAP and ICH will require that ICH pay RCAP a $3 million termination fee, in certain circumstances, should the merger not be consummated and ICH consummates a business combination transaction with another party other than RCAP. In addition, ICH has agreed to a 45-day exclusivity period subject to reimbursement of certain expenses of RCAP. Finally, on October 27, 2013, the Company executed a definitive merger agreement (the “Merger Agreement”) with RCAP, pursuant to which RCAP will acquire ICH and its subsidiaries, including Investors Capital Corporation, for a total consideration of approximately $52.5 million comprised of cash and RCAP stock. The closing of the transaction is subject to customary closing conditions, including FINRA approval of the proposed change in control, as well as approval of the transaction by ICH stockholders. The transaction is expected to close in the first quarter of 2014. | |
Organization_And_Basis_Of_Pres1
| Organization And Basis Of Presentation (Policy) | 6 Months Ended |
| Sep. 30, 2013 | |
| Organization And Basis Of Presentation [Abstract] | ' |
| Basis Of Presentation | ' |
| BASIS OF PRESENTATION: | |
| The condensed consolidated financial statements are unaudited and have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. In the opinion of management, the interim data includes all adjustments, consisting of normal recurring adjustments, necessary for a fair statement of the results for the periods presented. Because of the nature of the Company’s business, interim period results may not be indicative of full year or future results. | |
| The accompanying interim unaudited condensed consolidated financial statements of Investors Capital Holdings, Ltd. and its subsidiaries (the “Company”) have been prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”) for interim financial information and with the instructions to Quarterly Report on Form 10-Q. Accordingly, they do not include all of the information and footnotes required by US GAAP for complete financial statements. In the opinion of management, these financial statements contain all of the adjustments necessary for a fair presentation of the results of the interim periods presented. Operating results for the three months and six months period ended September 30, 2013 are not necessarily indicative of the results that may be expected for the year ending March 31, 2014. The balance sheet at March 31, 2013 has been derived from the audited financial statements at that date, but does not include all of the information and footnotes required by US GAAP for complete financial statement presentation. For further information, refer to the audited consolidated financial statements and footnotes thereto included in the Company’s Annual Report on Form 10-K (the “Form 10-K”) for the fiscal year ended March 31, 2013 filed with the SEC, for additional disclosures and a description of accounting policies. | |
| There have been no material changes from the critical accounting policies set forth in Item 7, “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” of our annual report on Form 10-K for the year ended March 31, 2013. Please refer to those sections for disclosures regarding the critical accounting policies related to our business | |
| Certain prior year items have been reclassified to conform to the current period’s presentation. These reclassifications had no effect on previously reported results of operations. All significant intercompany balances and transactions have been eliminated. The Company has evaluated subsequent events through the date of this filing. | |
Loans_To_Registered_Representa1
| Loans To Registered Representatives (Tables) | 6 Months Ended | |||||
| Sep. 30, 2013 | ||||||
| Loans To Registered Representatives [Abstract] | ' | |||||
| Schedule Of Loans To Registered Representatives | ' | |||||
| 30-Sep-13 | 31-Mar-13 | |||||
| Forgivable loans | $ | 1,353,806 | $ | 1,115,765 | ||
| Other loans | 619,483 | 604,264 | ||||
| Less: allowance | -222,596 | -232,596 | ||||
| Total loans | $ | 1,750,693 | $ | 1,487,433 | ||
Fair_Value_Measurements_Tables
| Fair Value Measurements (Tables) | 6 Months Ended | ||||||||||||
| Sep. 30, 2013 | |||||||||||||
| Fair Value Measurements [Abstract] | ' | ||||||||||||
| Schedule Of Fair Value Hierarchy For Financial Assets And Liabilities Measured On Recurring Basis | ' | ||||||||||||
| Fair Value Measurements on Recurring Basis | |||||||||||||
| Assets: | Total | Level 1 | Level 2 | Level 3 | |||||||||
| Securities owned at fair value | |||||||||||||
| Mutual funds | $ | 273,919 | $ | 273,919 | $ | - | $ | - | |||||
| Equities | 1,306 | 1,306 | - | - | |||||||||
| Asset backed securities | 1,806 | - | 1,806 | - | |||||||||
| Total Assets | $ | 277,031 | $ | 275,225 | $ | 1,806 | $ | - | |||||
| Liabilities: | |||||||||||||
| Securities sold, not yet purchased at fair value | |||||||||||||
| Exchange traded funds | $ | 17,818 | $ | 17,818 | $ | - | $ | - | |||||
| Equities | 26,880 | 26,880 | - | - | |||||||||
| Total Liabilities | $ | 44,698 | $ | 44,698 | $ | - | $ | - | |||||
| The following table presents the Company's fair value hierarchy for those financial assets and liabilities measured at fair value as of March 31, 2013: | |||||||||||||
| Fair Value Measurements on Recurring Basis | |||||||||||||
| Total | Level 1 | Level 2 | Level 3 | ||||||||||
| Assets: | |||||||||||||
| Securities owned at fair value | |||||||||||||
| Mutual funds | $ | 256,509 | $ | 256,509 | $ | - | $ | - | |||||
| Equities | 354 | 354 | - | - | |||||||||
| Asset backed securities | 2,040 | - | 2,040 | - | |||||||||
| Total assets | $ | 258,903 | $ | 256,863 | $ | 2,040 | $ | - | |||||
| Liabilities: | |||||||||||||
| Securities sold, not yet purchased at fair value | |||||||||||||
| Equities | 28,946 | 28,946 | - | - | |||||||||
| Total Liabilities | $ | 28,946 | $ | 28,946 | $ | - | $ | - | |||||
Stock_Based_Compensation_Table
| Stock Based Compensation (Tables) | 6 Months Ended | ||||||||||
| Sep. 30, 2013 | |||||||||||
| Stock Based Compensation [Abstract] | ' | ||||||||||
| Schedule Of Non-Vested Activity | ' | ||||||||||
| Weighted Ave | Weighted Average | ||||||||||
| Shares | Stock Price | Vested Life | Fair Value | ||||||||
| Non-vested at July 1, 2013 | 413,634 | $ | 3.84 | 2.53 years | $ | 1,588,355 | |||||
| Granted | - | - | |||||||||
| Less: vested | -24,816 | 3.93 | -97,527 | ||||||||
| Less: canceled | - | - | - | ||||||||
| Non-vested at September 30, 2013 | 388,818 | $ | 3.83 | 2.30 years | $ | 1,489,173 | |||||
| Weighted Ave | Weighted Average | ||||||||||
| Shares | Stock Price | Vested Life | Fair Value | ||||||||
| Non-vested at July 1, 2012 | 63,976 | $ | 4.41 | 2.05 years | $ | 282,134 | |||||
| Granted | - | - | - | ||||||||
| Less: vested | -15,885 | 4.58 | -72,753 | ||||||||
| Less: canceled | -589 | 5.68 | -3,346 | ||||||||
| Non-vested at September 30, 2012 | 47,502 | $ | 4.33 | 1.95 years | $ | 205,684 | |||||
| The Company’s net loss for the three months ended September 30, 2013 includes $0.05 million of compensation costs related to the Company’s grants of restricted stock to employees, $0.01 for grants to directors and $0.04 million for grants to independent representatives under the Plans. In the prior period, the Company’s net income included $0.02 million in stock compensation to directors, and $0.03 million in stock compensation to independent representatives under the Equity Plans. | |||||||||||
| The following activity occurred during the six months ended September 30, 2013 and 2012: | |||||||||||
| Weighted Ave | Weighted Average | ||||||||||
| Shares | Stock Price | Vested Life | Fair Value $ | ||||||||
| Non-vested at 4/1/2013 | 440,437 | $ | 3.85 | 2.74 years | $ | 1,695,682 | |||||
| Granted | - | - | - | ||||||||
| Less: vested | -50,800 | $ | 3.94 | -200,152 | |||||||
| Less: canceled | -819 | 4.46 | -3,653 | ||||||||
| Non-vested at 9/30/2013 | 388,818 | $ | 3.83 | 2.30 years | $ | 1,489,173 | |||||
| Weighted Ave | Weighted Average | ||||||||||
| Shares | Stock Price | Vested Life | Fair Value $ | ||||||||
| Non-vested at 4/1/2012 | 77,402 | $ | 4.41 | 2.54 years | $ | 341,343 | |||||
| Granted | - | - | - | ||||||||
| Less: vested | -25,125 | 4.48 | -112,560 | ||||||||
| Less: canceled | -4,775 | 4.88 | -23,302 | ||||||||
| Non-vested at 9/30/2012 | 47,502 | $ | 4.33 | 1.95 years | $ | 205,684 | |||||
| Summary Of Employee And Director Fixed Stock Options | ' | ||||||||||
| Employee | |||||||||||
| 2013 | 2012 | ||||||||||
| Fixed Options | Weighted-Average | Weighted-Average | |||||||||
| Shares | Exercise Price | Shares | Exercise Price | ||||||||
| Outstanding at beginning of period | 150,000 | $1.00 | 150,000 | $1.00 | |||||||
| Granted | - | - | |||||||||
| Canceled | - | - | |||||||||
| Exercised | - | - | |||||||||
| Outstanding at end of period | 150,000 | $1.00 | 150,000 | $1.00 | |||||||
| Options exercisable at period end | 150,000 | 150,000 | |||||||||
| Weighted-average fair value of | |||||||||||
| options granted during the period | - | - | |||||||||
| Summary Of Employee And Directors' Fixed Stock Options Outstanding | ' | ||||||||||
| Options Outstanding | Options Exercisable | ||||||||||
| Range of Exercise Prices | Number Outstanding | Weighted-Average RemainingContractual Life | Exercise Price | Number Exercisable | Weighted-Average Exercise Price | ||||||
| $ | 1.00 | 150,000 | $ | 1.00 | 150,000 | $ | 1.00 | ||||
Segment_Information_Tables
| Segment Information (Tables) | 6 Months Ended | |||||||||||
| Sep. 30, 2013 | ||||||||||||
| Segment Information [Abstract] | ' | |||||||||||
| Schedule Of Segment Reporting | ' | |||||||||||
| 30-Sep-13 | ||||||||||||
| Commissions | Advisory | ICH | ICH Securities | Totals | ||||||||
| Non-interest revenue | $ | 17,611,190 | 4,607,317 | -16,729 | - | $ | 22,201,778 | |||||
| Revenue from transaction with | ||||||||||||
| other operating segments: | $ | 297,889 | - | - | $ | 297,889 | ||||||
| Interest and dividend income, net | $ | 76,019 | - | 2 | 5 | $ | 76,026 | |||||
| Depreciation and amortization | $ | 59,430 | 917 | - | - | $ | 60,347 | |||||
| Income (loss) from operations | $ | -1,509,307 | 660,423 | -65,464 | 5 | $ | -914,343 | |||||
| Period end total assets | $ | 17,071,481 | 708,145 | 2,714,727 | 10,364 | $ | 20,504,717 | |||||
| Corporate items and eliminations | $ | - | - | -1,477,175 | - | $ | -1,477,175 | |||||
| 30-Sep-12 | ||||||||||||
| Commissions | Advisory | ICH | ICH Securities | Totals | ||||||||
| Non-interest revenue | $ | 16,237,978 | $ | 4,033,714 | $ | -17,445 | $ | - | $ | 20,254,247 | ||
| Revenue from transaction with | ||||||||||||
| other operating segments: | $ | 266,558 | - | - | $ | 266,558 | ||||||
| Interest and dividend income, net | $ | 68,513 | - | 7 | - | $ | 68,520 | |||||
| Depreciation and amortization | $ | 79,829 | 1,167 | - | - | $ | 80,996 | |||||
| Income (loss) from operations | $ | 10,888 | 532,696 | -113,951 | 7 | $ | 429,640 | |||||
| Period end total assets | $ | 13,933,230 | 456,591 | 2,912,360 | 10,343 | $ | 17,312,524 | |||||
| Corporate items and eliminations | $ | - | - | -1,728,824 | - | $ | -1,728,824 | |||||
| + | ||||||||||||
| Segment reporting primarily based on revenue components is as follows for the six months ended: | ||||||||||||
| 30-Sep-13 | ||||||||||||
| Commissions | Advisory | ICH | ICH Securities | Totals | ||||||||
| Non-interest revenue | $ | 36,168,380 | 9,084,641 | -32,873 | - | $ | 45,220,148 | |||||
| Revenue from transaction with | ||||||||||||
| other operating segments: | $ | 632,264 | - | - | - | $ | 632,264 | |||||
| Interest and dividend income, net | $ | 140,638 | 2 | 10 | $ | 140,650 | ||||||
| Depreciation and amortization | $ | 119,912 | 917 | - | - | $ | 120,829 | |||||
| Income (loss) from operations | $ | -2,607,945 | 1,145,571 | -122,087 | 10 | $ | -1,584,451 | |||||
| Period end total assets | $ | 17,071,481 | 708,145 | 2,714,727 | 10,364 | $ | 20,504,717 | |||||
| Corporate items and eliminations | $ | - | - | -1,477,175 | - | $ | -1,477,175 | |||||
| 30-Sep-12 | ||||||||||||
| Commissions | Advisory | ICH | ICH Securities | Totals | ||||||||
| Non-interest revenue | $ | 32,799,117 | $ | 8,209,373 | $ | -30,373 | $ | - | $ | 40,978,117 | ||
| Revenue from transaction with | ||||||||||||
| other operating segments: | $ | 496,474 | - | - | - | $ | 496,474 | |||||
| Interest and dividend income, net | $ | 147,160 | - | 13 | - | $ | 147,173 | |||||
| Depreciation and amortization | $ | 162,850 | 1,167 | - | - | $ | 164,017 | |||||
| Income (loss) from operations | $ | 29,554 | 1,140,811 | -291,715 | 13 | $ | 878,663 | |||||
| Period end total assets | $ | 13,933,230 | 456,591 | 2,912,360 | 10,343 | $ | 17,312,524 | |||||
| Corporate items and eliminations | $ | - | - | -1,728,824 | - | $ | -1,728,824 | |||||
Organization_And_Basis_Of_Pres2
| Organization And Basis Of Presentation (Details) (USD $) | Jan. 24, 2013 |
| Organization And Basis Of Presentation [Abstract] | ' |
| Cash purchase price of Advisors Direct, Incorporated | $32,500 |
Loans_To_Registered_Representa2
| Loans To Registered Representatives (Narrative) (Details) (USD $) | 3 Months Ended | 6 Months Ended | |||
| Sep. 30, 2013 | Sep. 30, 2012 | Sep. 30, 2013 | Sep. 30, 2012 | Mar. 31, 2013 | |
| Loans charged to commission expense | $82,950 | $86,379 | $218,211 | $174,359 | ' |
| Regulatory matter, settled date | ' | ' | 27-Oct-10 | ' | ' |
| Regulatory matter, amount due | 619,483 | ' | 619,483 | ' | 604,264 |
| Maximum [Member] | ' | ' | ' | ' | ' |
| Stipulation for loans forgiven, period to remain licensed with company, years | ' | ' | '5 years | ' | ' |
| Interest charged on loans, percentage, maximum | ' | ' | 8.25% | ' | ' |
| Minimum [Member] | ' | ' | ' | ' | ' |
| Stipulation for loans forgiven, period to remain licensed with company, years | ' | ' | '1 year | ' | ' |
| Interest charged on loans, percentage, minimum | ' | ' | 4.25% | ' | ' |
| Registered Representative [Member] | ' | ' | ' | ' | ' |
| Regulatory matter, amount due | $304,758 | ' | $304,758 | ' | $330,587 |
Loans_To_Registered_Representa3
| Loans To Registered Representatives (Schedule Of Loans To Registered Representatives) (Details) (USD $) | Sep. 30, 2013 | Mar. 31, 2013 |
| Loans To Registered Representatives [Abstract] | ' | ' |
| Forgivable loans | $1,353,806 | $1,115,765 |
| Other loans | 619,483 | 604,264 |
| Less: allowance | -222,596 | -232,596 |
| Total loans | $1,750,693 | $1,487,433 |
Income_Taxes_Details
| Income Taxes (Details) (USD $) | Mar. 31, 2012 |
| In Millions, unless otherwise specified | |
| Income Taxes [Abstract] | ' |
| Valuation Allowance, netted against its deferred tax assets | $0.50 |
Fair_Value_Measurements_Schedu
| Fair Value Measurements (Schedule Of Fair Value Hierarchy For Financial Assets And Liabilities Measured On Recurring Basis) (Details) (USD $) | Sep. 30, 2013 | Mar. 31, 2013 |
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' |
| Non-qualified deferred compensation investment | $2,148,276 | $1,771,044 |
| Fair Value Measurements On Recurring Basis [Member] | ' | ' |
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' |
| Mutual funds | 273,919 | 256,509 |
| Equities | 1,306 | 354 |
| Asset backed securities | 1,806 | 2,040 |
| Total assets | 277,031 | 258,903 |
| Fair Value Measurements On Recurring Basis [Member] | Level 1 [Member] | ' | ' |
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' |
| Mutual funds | 273,919 | 256,509 |
| Equities | 1,306 | 354 |
| Total assets | 275,225 | 256,863 |
| Fair Value Measurements On Recurring Basis [Member] | Level 2 [Member] | ' | ' |
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' |
| Asset backed securities | 1,806 | 2,040 |
| Total assets | 1,806 | 2,040 |
| Fair Value Measurements On Recurring Basis [Member] | Level 3 [Member] | ' | ' |
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' |
| Mutual funds | ' | ' |
| Equities | ' | ' |
| Asset backed securities | ' | ' |
| Total assets | ' | ' |
| Securities Sold, Not yet Purchased [Member] | Fair Value Measurements On Recurring Basis [Member] | ' | ' |
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' |
| Exchange traded funds | 17,818 | ' |
| Equities | 26,880 | 28,946 |
| Total liabilities | 44,698 | 28,946 |
| Securities Sold, Not yet Purchased [Member] | Fair Value Measurements On Recurring Basis [Member] | Level 1 [Member] | ' | ' |
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' |
| Exchange traded funds | 17,818 | ' |
| Equities | 26,880 | 28,946 |
| Total liabilities | 44,698 | 28,946 |
| Securities Sold, Not yet Purchased [Member] | Fair Value Measurements On Recurring Basis [Member] | Level 3 [Member] | ' | ' |
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' |
| Exchange traded funds | ' | ' |
| Equities | ' | ' |
| Total liabilities | ' | ' |
NonQualified_Deferred_Compensa1
| Non-Qualified Deferred Compensation Plan (Details) (USD $) | 3 Months Ended | 6 Months Ended | ||
| Sep. 30, 2013 | Sep. 30, 2012 | Sep. 30, 2013 | Sep. 30, 2012 | |
| Non-Qualified Deferred Compensation Plan [Abstract] | ' | ' | ' | ' |
| Total amount of deferred compensation plan | $149,225 | $108,710 | $302,337 | $214,432 |
Litigation_And_Regulatory_Matt1
| Litigation And Regulatory Matters (Details) (USD $) | 6 Months Ended | 12 Months Ended |
| Sep. 30, 2013 | Mar. 31, 2013 | |
| Litigation And Regulatory Matters [Abstract] | ' | ' |
| Exposure limit of errors, minimum | $100,000 | ' |
| Exposure limit of errors, aggregate maximum | 1,000,000 | ' |
| Exposure limit of errors, after threshold | 150,000 | ' |
| Percent of coinsurance after threshold | 10.00% | ' |
| Maximum exposure to damages and costs related to fraudulent activities | 350,000 | ' |
| Legal Fees | 2,671,834 | 1,534,660 |
| Litigation for single class action trustee settlement | 2,005,000 | ' |
| Amount due from insurance carrier | $1,000,000 | ' |
Stock_Based_Compensation_Narra
| Stock Based Compensation (Narrative) (Details) (USD $) | 3 Months Ended | 6 Months Ended | 6 Months Ended | 3 Months Ended | 6 Months Ended | 3 Months Ended | 6 Months Ended | 3 Months Ended | |||||
| Sep. 30, 2013 | Sep. 30, 2013 | Sep. 30, 2012 | Sep. 30, 2013 | Sep. 30, 2013 | Sep. 30, 2013 | Sep. 30, 2013 | Sep. 30, 2012 | Sep. 30, 2012 | Sep. 30, 2013 | Sep. 30, 2013 | Sep. 30, 2012 | Sep. 30, 2012 | |
| Maximum [Member] | Minimum [Member] | Directors [Member] | Directors [Member] | Directors [Member] | Directors [Member] | Independent Representatives [Member] | Independent Representatives [Member] | Independent Representatives [Member] | Independent Representatives [Member] | ||||
| Equity Incentive Plans [Member] | Equity Incentive Plans [Member] | Equity Incentive Plans [Member] | Equity Incentive Plans [Member] | ||||||||||
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
| Stock granted under plan, vesting period | ' | ' | ' | '7 years | '1 year | ' | ' | ' | ' | ' | ' | ' | ' |
| Compensation costs related to grants of restricted stock | $50,000 | $100,000 | ' | ' | ' | $10,000 | $20,000 | $20,000 | $20,000 | $40,000 | $80,000 | $60,000 | $30,000 |
| Intrinsic value of stock options | $654,000 | $654,000 | $450,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Stock_Based_Compensation_Sched
| Stock Based Compensation (Schedule Of Non-Vested Activity) (Details) (USD $) | 3 Months Ended | 6 Months Ended | ||
| Sep. 30, 2013 | Sep. 30, 2012 | Sep. 30, 2013 | Sep. 30, 2012 | |
| Stock Based Compensation [Abstract] | ' | ' | ' | ' |
| Non-vested at beginning of period, Shares | 413,634 | 63,976 | 440,437 | 77,402 |
| Less: vested, Shares | -24,816 | -15,885 | -50,800 | -25,125 |
| Less: canceled, Shares | ' | -589 | -819 | -4,775 |
| Non-vested at end of period, Shares | 388,818 | 47,502 | 388,818 | 47,502 |
| Non-vested at beginning of period, Weighted Average Stock Price | $3.84 | $4.41 | $3.85 | $4.41 |
| Less: vested, Weighted Average Stock Price | $3.93 | $4.58 | $3.94 | $4.48 |
| Less: cancelled, Weighted Average Stock Price | ' | $5.68 | $4.46 | $4.88 |
| Non-vested at end of period, Weighted Average Stock Price | $3.83 | $4.33 | $3.83 | $4.33 |
| Non-vested at beginning of period, Weighted Average Vested Life, years | '2 years 6 months 11 days | '2 years 18 days | '2 years 8 months 27 days | '2 years 6 months 15 days |
| Non-vested at end of period, Weighted Average Vested Life, years | '2 years 3 months 18 days | '1 year 11 months 12 days | '2 years 3 months 18 days | '1 year 11 months 12 days |
| Non-vested at beginning of period, Fair Value | $1,588,355 | $282,134 | $1,695,682 | $341,343 |
| Less: vested, Fair Value | -97,527 | -72,753 | -200,152 | -112,560 |
| Less: canceled, Fair Value | ' | -3,346 | -3,653 | -23,302 |
| Non-vested at end of period, Fair Value | $1,489,173 | $205,684 | $1,489,173 | $205,684 |
Stock_Based_Compensation_Summa
| Stock Based Compensation (Summary Of Employee And Director Fixed Stock Options) (Details) (USD $) | 6 Months Ended | |
| Sep. 30, 2013 | Sep. 30, 2012 | |
| Stock Based Compensation [Abstract] | ' | ' |
| Outstanding at beginning of period, Shares | 150,000 | 150,000 |
| Outstanding at beginning of year, Weighted-Average Exercise Price | $1 | $1 |
| Granted, Shares | ' | ' |
| Canceled, Shares | ' | ' |
| Exercised, Shares | ' | ' |
| Outstanding at period end, Shares | 150,000 | 150,000 |
| Outstanding at period end, Weighted-Average Exercise Price | $1 | $1 |
| Options exercisable at period end, Shares | 150,000 | 150,000 |
Stock_Based_Compensation_Summa1
| Stock Based Compensation (Summary Of Employee And Directors' Fixed Stock Options Outstanding) (Details) (USD $) | 6 Months Ended | |||
| Sep. 30, 2013 | Mar. 31, 2013 | Sep. 30, 2012 | Mar. 31, 2012 | |
| Stock Based Compensation [Abstract] | ' | ' | ' | ' |
| Options Outstanding, Range of Exercise Prices | $1 | ' | ' | ' |
| Options Outstanding, Number Outstanding | 150,000 | 150,000 | 150,000 | 150,000 |
| Options Exercisable, Weighted-Average Remaining Contractual Life | ' | ' | ' | ' |
| Options Exercisable, Exercise Price | $1 | ' | ' | ' |
| Options Exercisable, Number Exercisable | 150,000 | ' | 150,000 | ' |
| Options Exercisable, Weighted-Average Exercise Price | $1 | ' | ' | ' |
Segment_Information_Schedule_O
| Segment Information (Schedule Of Segment Reporting) (Details) (USD $) | 3 Months Ended | 6 Months Ended | ||
| Sep. 30, 2013 | Sep. 30, 2012 | Sep. 30, 2013 | Sep. 30, 2012 | |
| Segment Reporting Information [Line Items] | ' | ' | ' | ' |
| Non-interest revenue | $22,201,778 | $20,254,247 | $45,220,148 | $40,978,117 |
| Revenue from transaction with other operating segments: | 297,889 | 266,558 | 632,264 | 496,474 |
| Interest and dividend income, net | 76,026 | 68,520 | 140,650 | 147,173 |
| Depreciation and amortization | 60,347 | 80,996 | 120,829 | 164,017 |
| Income (loss) from operations | -914,343 | 429,640 | -1,584,451 | 878,663 |
| Period end total assets | 20,504,717 | 17,312,524 | 20,504,717 | 17,312,524 |
| Corporate items and eliminations | -1,477,175 | -1,728,824 | -1,477,175 | -1,728,824 |
| Commissions [Member] | ' | ' | ' | ' |
| Segment Reporting Information [Line Items] | ' | ' | ' | ' |
| Non-interest revenue | 17,611,190 | 16,237,978 | 36,168,380 | 32,799,117 |
| Revenue from transaction with other operating segments: | 297,889 | 266,558 | 632,264 | 496,474 |
| Interest and dividend income, net | 76,019 | 68,513 | 140,638 | 147,160 |
| Depreciation and amortization | 59,430 | 79,829 | 119,912 | 162,850 |
| Income (loss) from operations | -1,509,307 | 10,888 | -2,607,945 | 29,554 |
| Period end total assets | 17,071,481 | 13,933,230 | 17,071,481 | 13,933,230 |
| Advisory [Member] | ' | ' | ' | ' |
| Segment Reporting Information [Line Items] | ' | ' | ' | ' |
| Non-interest revenue | 4,607,317 | 4,033,714 | 9,084,641 | 8,209,373 |
| Depreciation and amortization | 917 | 1,167 | 917 | 1,167 |
| Income (loss) from operations | 660,423 | 532,696 | 1,145,571 | 1,140,811 |
| Period end total assets | 708,145 | 456,591 | 708,145 | 456,591 |
| ICH [Member] | ' | ' | ' | ' |
| Segment Reporting Information [Line Items] | ' | ' | ' | ' |
| Non-interest revenue | -16,729 | -17,445 | -32,873 | -30,373 |
| Interest and dividend income, net | 2 | 7 | 2 | 13 |
| Income (loss) from operations | -65,464 | -113,951 | -122,087 | -291,715 |
| Period end total assets | 2,714,727 | 2,912,360 | 2,714,727 | 2,912,360 |
| Corporate items and eliminations | -1,477,175 | -1,728,824 | -1,477,175 | -1,728,824 |
| ICH Securities [Member] | ' | ' | ' | ' |
| Segment Reporting Information [Line Items] | ' | ' | ' | ' |
| Interest and dividend income, net | 5 | ' | 10 | ' |
| Income (loss) from operations | 5 | 7 | 10 | 13 |
| Period end total assets | $10,364 | $10,343 | $10,364 | $10,343 |
Subsequent_Events_Details
| Subsequent Events (Details) (RSC Capital Corporation [Member], Subsequent Event [Member], USD $) | Oct. 01, 2012 |
| In Millions, except Per Share data, unless otherwise specified | |
| RSC Capital Corporation [Member] | Subsequent Event [Member] | ' |
| Subsequent Event [Line Items] | ' |
| Sale of ICH | $52.20 |
| Sale of ICH, price per share | $7.35 |
| Merger agreement termination fee | $3 |